Inspired by this post I have six points for discussion. Choose one of them and start discussing.
- High probability of success - significance of the historic trials in terms of probability of success of Pillars 2 and 3 ( Breast Cancer and AML trials )
- The baseline value of Pillars 2 and 3 to Big Pharma (in the context of probability shown by #1)
- The potential stratospheric value of Pillar 1 to Big Pharma (lots of great info has been shared by @Mason14 in this post)
- That Big Pharma initiate most buyout transactions during Preclinical, Phase 1 or 2
- That RACE is significantly undervalued to peers in the US
- The effort that management are putting into getting this right
Understanding RAC
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
-0.140(7.61%) |
Mkt cap ! $289.4M | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.89 | $1.70 | $456.4K | 259.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 8662 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |